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ABSTRACT
Background Inflammatory bowel diseases,
encompassing Crohn’s disease and ulcerative colitis, are
characterised by persistent leucocyte tissue infiltration
leading to perpetuation of an inappropriate inflammatory
cascade. The neuronal guidance molecule netrin-1 has
recently been implicated in the orchestration of
leucocyte trafficking during acute inflammation. We
therefore hypothesised that netrin-1 could modulate
leucocyte infiltration and disease activity in a model of
inflammatory bowel disease.
Design DSS-colitis was performed in mice with partial
genetic netrin-1 deficiency (Ntn-1+/ mice) or wild-type
mice treated with exogenous netrin-1 via osmotic pump
to examine the role of endogenous and therapeutically
administered netrin-1. These studies were supported by
in vitro models of transepithelial migration and intestinal
epithelial barrier function.
Results Consistent with our hypothesis, we observed
induction of netrin-1 during intestinal inflammation in vitro
or in mice exposed to experimental colitis. Moreover,
mice with partial netrin-1 deficiency demonstrated an
exacerbated course of DSS-colitis compared to littermate
controls, with enhanced weight loss and colonic
shortening. Conversely, mice treated with exogenous
mouse netrin-1 experienced attenuated disease severity.
Importantly, permeability studies and quantitative
assessment of apoptosis reveal that netrin-1 signalling
events do not alter mucosal permeability or intestinal
epithelial cell apoptosis. In vivo studies of leucocyte
transmigration demonstrate suppression of neutrophil
trafficking as a key function mediated by endogenous or
exogenously administered netrin-1. Finally, genetic
studies implicate the A2B adenosine receptor in
netrin-1-mediated protection during DSS-colitis.
Conclusions The present study identifies a previously
unrecognised role for netrin-1 in attenuating experimental
colitis through limitation of neutrophil trafficking.
INTRODUCTION
Netrin-1 was originally identified as a diffusible
factor released by neural floor plate cells in the
developing spinal cord that regulates axonal
outgrowth.1 Studies have expanded to peripheral
organs where netrin-1 modulates cell development,
migration and inflammatory end points to reduce
tissue inflammation.2e10
Inflammatory bowel diseases (IBDs), encapsu-
lating Crohn’s disease (CD) and ulcerative colitis
(UC), are heterogeneous diseases affecting the
gastrointestinal tract that occur at the cross section
of genetics and environment.11 12 Disruption of the
intestinal epithelial barrier and aberrant accumula-
tion of leucocytes within the intestinal lamina
propria (LP) leading to continued mucosal damage
characterise CD and UC.13 While biologics offer
more targeted treatment, the search for increased
specificity in IBD therapeutics continues.14
The role of netrin-1 in IBD remains undefined.
Previous reports demonstrate enhanced netrin-1
expression in the intestinal epithelium of patients
with CD or UC.15 Hypoxia-dependent signalling
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Significance of this study
What is already known about this subject?
< As a neuronal guidance molecule, netrin-1 has
been implicated in the developing brain
< Previous studies have found high expression
levels of netrin-1 in the intestine, including in
patients with inflammatory bowel disease (IBD)
< Netrin-1 has been implicated in immune functions
What are the new findings?
< At present, the functional role of netrin-1 in IBD
is unknown. As such, our studies provide, for the
first time, evidence for a protective role of netrin-
1 signalling in an experimental model of IBD
< Mice with a deficiency of netrin-1 experience
enhanced disease severity during experimental
colitis
< Treatment with exogenous netrin-1 using
osmotic pump delivery attenuates experimental
colitis
< Netrin-1 does not alter epithelial permeability or
apoptosis in vivo but directly limits neutrophil
trafficking to attenuate disease
How might it impact on clinical practice in the
foreseeable future?
< Continuous low-dose administration of netrin-1
as demonstrated here in an experimental model
of colitis may be exploited as a therapeutic
agent directed towards the suppression of
neutrophil infiltration in patients with IBD
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induces intestinal mucosal netrin-1 expression,2 with recent
reports demonstrating a tissue-protective role for the hypoxic
response in IBD.16e19 This notion coupled with an inhibitory
effect of netrin-1 on leucocyte transmigration2 6 led us to
hypothesise that netrin-1 may mediate tissue protection in IBD.
We established that netrin-1 expression was enhanced within the
colonic mucosa during murine colitis. Deficiency of netrin-1
resulted in exacerbated murine colitis accompanied by exagger-
ated neutrophil infiltration into the colonic LP. This was attenu-
ated by recombinant netrin-1. Mechanistic studies reveal that
netrin-1 mediates its effects through interaction with migrating
leucocytes without directly modulating intestinal epithelial
barrier function or epithelial cell apoptosis. Furthermore, we
demonstrate a role for the purinergic signalling pathway in
netrin-1-mediated protection. Our data demonstrate, for the first
time, a protective role for netrin-1 in experimental colitis.
MATERIALS AND METHODS
Cell culture
Caco-2, T84 and HMEC-1 cells were cultured as described.20e22
Time course studies were performed with recombinant human
tumor necrosis factor (TNF) a, interleukin (IL) b and interferon
(IFN) g.
DSS-colitis
Netrin-1 heterozygous mice (Ntn-1+/ mice), A2B adenosine
receptor-deficient (Adora2b/) mice, matched littermate
controls or C57BL/6 mice were used in DSS (dextran sulphate
sodium) studies as described.23e25 Recombinant netrin-1 was
delivered with subcutaneous osmotic pumps (1 mg/mouse/day).
Anti-UNC5B antibody was administered intraperitoneally
(800 mg/kg/mouse).
Flow cytometry
Flow cytometric analysis of LP leucocytes with anti-mouse
GR-1, SiglecF, Ly-6G, Ly-6C, CD11b, CD45, LIVE/DEAD cell
stain or isotype controls was performed as described.26
Immunohistochemistry
Paraffin-embedded tissues were incubated with anti-mouse
netrin-1 followed by DAB (3,3-diaminobenzidine substrate)
development and methyl green counterstain.
Immunofluorescence
Frozen tissues were incubated with anti-PGP9.5 or anti-CGRP,
followed by fluorescent detection and DAPI (4’,6-diamidino-2-
phenylindole) counterstain.
Western blotting
Tissue immunoblotting was performed as described.2
Real-time reverse transcriptase polymerase chain reaction
(RT-PCR)
Messenger RNA (mRNA) analysis was performed as described.2
In vivo permeability
FITC-labelled (fluorescein isothiocyanate) dextran permeability
was performed as described.19
TUNEL assay
TUNEL (deoxynucleotidyl transferase–mediated deoxyuridine
triphosphate) assay using paraffin-embedded tissues was
performed as per manufacturer ’s instructions.
In vitro permeability
Permeability studies in Caco-2 cells treated with DSS or cyto-
kines were performed as described.20
In vitro transmigration
Polymorphonuclear leucocytes (PMN) transmigration was
performed as described.2
Statistical analysis
Statistical comparisons were made with GraphPad Prism Anal-
ysis software using analysis of variance (ANOVA) or Student t
test where appropriate and are expressed at mean6SEM.
Further details can be found in the supplementary material.
RESULTS
Induction of netrin-1 expression during intestinal inflammation
Previous study suggests that inflammation regulates netrin-1
expression.27 To examine the effects of inflammation on intes-
tinal expression of netrin-1, we assessed netrin-1 mRNA levels in
human intestinal epithelial cell lines (T84 and Caco-2; figure 1A,
B, respectively) and a human microvascular endothelial cell line
(HMEC-1; figure 1C) following 2 h and 6 h stimulation with
a combination of mediators closely associated with IBD patho-
genesis (cytomix; TNFa, IL-1b and IFNg). Netrin-1 mRNA
expression significantly increased in all cell lines following 6 h
treatment. To examine this response and identify the cellular
source of netrin-1 in vivo, netrin-1 expression was analysed in
a DSS-colitis time course (figure 1DeG). Immunohistochemical
analysis demonstrated robust expression of netrin-1 in colonic
epithelial cells and in myenteric neural units (figure 1D; arrows
identify staining of relevant cells). PCR analysis of HMEC-1 cells
revealed induction of netrin-1 mRNA upon inflammatory
stimulation (figure 1C); however, immunohistochemistry failed
to show netrin-1 expression in colonic endothelial cells during
DSS. Netrin-1 expression remained specifically localised to the
intestinal epithelium and the myenteric neural units of the colon
throughout the DSS time course, with the appearance of
increasing expression over time. mRNA (figure 1E) and western
blotting (figure 1F,G) confirmed a quantifiable increase in netrin-
1 expression in the whole colon (figure 1E,F) and in the mucosal
lining layer (figure 1G) following 7 days of DSS. These obser-
vations indicate induction of netrin-1 expression during experi-
mental colitis with significant expression by the epithelium.
Mice with partial netrin-1 deficiency demonstrate reduced
netrin-1 expression and normal enteric neuronal anatomy in
experimental colitis
Netrin-1-deficient mice do not survive beyond postnatal day 3
due to improper axonal development.28 Mice with partial netrin-
1 deficiency (Ntn-1+/) develop normally compared to wild-type
controls (Ntn-1+/+).28 Having observed netrin-1 expression in
the colon following experimental colitis, we assessed netrin-1
expression in Ntn-1+/- mice following DSS. Netrin-1 expression
in Ntn-1+/ mice remained below Ntn-1+/+ at baseline and was
similarly reduced following DSS (figure 2AeC). Therefore, we
conclude that during DSS-colitis, endogenous netrin-1 levels are
dramatically diminished in Ntn-1+/ mice.
Initial findings demonstrated netrin-1 expression in colonic
myenteric neural units (figure 1D); therefore, we compared the
colonic neuronal anatomy of Ntn-1+/ and Ntn-1+/+ mice at
baseline and during DSS. Staining for peripheral nerve fibres
(anti-PGP9.5) revealed no appreciable difference in the neuronal
anatomy of the colon of Ntn-1+/ mice compared to Ntn-1+/+
prior to or during DSS-colitis (figure 2D). Additionally, no
difference in pain nerve fibres was observed between groups
(anti-CGRP; data not shown). We therefore conclude that mice
with netrin-1 insufficiency do not demonstrate altered neuronal
patterning during DSS.
696 Gut 2012;61:695e705. doi:10.1136/gutjnl-2011-300012
Inflammatory bowel disease
 o
n
 February 26, 2020 at M
aynooth University Library. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2011-300012 on 3 August 2011. Downloaded from 
Partial netrin-1 deficiency exacerbates disease activity in
a model of experimental colitis
Recent study indicates that mice with partial genetic defi-
ciency of netrin-1 (Ntn-1+/) experience an enhanced inflam-
matory response in models of acute inflammation,2 8 9 thus
prompting our investigation of these mice in experimental
colitis. Consistent with our hypothesis, we observed that
Ntn-1+/ mice experienced increased disease severity compared
to wild-type controls (Ntn-1+/+) as measured by weight loss,
disease activity index, colonic shortening and histologic
damage (figure 3AeE, respectively). Thus, we conclude that
partial deficiency of netrin-1 is detrimental to the development
of DSS-colitis.
Partial netrin-1 deficiency results in heightened colonic
inflammation in experimental colitis
Previous observations demonstrate that netrin-1 can inhibit
leucocyte tissue infiltration, with studies demonstrating netrin-1
inhibition of neutrophil and monocyte recruitment in acute
inflammation.2 6e9 Inappropriate neutrophil accumulation
within the LP is a key feature of early and active UC.29e31 DSS-
colitis is characterised by rapid neutrophil influx into the LP,
closely modelling human disease.32 Rapid onset of weight loss in
the Ntn-1+/ mice prompted investigation of early and late
disease activity. Flow cytometric analysis of leucocytes isolated
from the whole colon following 3 and 7 days of DSS revealed no
significant difference in dendritic cell (CD11c+MHCIIHi),
Figure 1 Netrin-1 expression in
response to inflammation. T84
intestinal epithelial cells (A), Caco-2
intestinal epithelial cells (B) or HMEC-1
microvascular endothelial cells (C) were
exposed to a combination of tumor
necrosis factor (TNF) a, interleukin (IL)
1b and interferon (IFN) g (cytomix; all
at 10 ng/ml) or vehicle (0.1% bovine
serum albumin (BSA)/phosphate-
buffered saline (PBS)) for 2 h or 6 h
followed by total RNA isolation and
analysis of netrin-1 transcript levels
(NTN-1). NTN-1 expression was
calculated relative to b-actin and
expressed as fold change relative to
vehicle treatment6SEM for each
timepoint. Results are derived from
independent experiments at each
individual time point, performed in
triplicate. (D) Gender-, age- and weight-
matched C57BL/6 mice exposed to
water or DSS (4.5%) over a timecourse
of 7 days were sacrificed at 2-day
intervals post DSS administration (days
0, 1, 3, 5 and 7), and whole colon was
harvested by blunt dissection. Paraffin-
embedded sections of whole colon
were deparaffinised and rehydrated for
immunohistochemical staining with
a chicken anti-netrin-1 specific antibody
(1:100) followed by DAB development
(brown staining) and counterstaining
with methyl green (green staining).
Primary antibody was omitted as
negative control (control).
Representative images were acquired
at 10X using a Nikon Eclipse Ti-S
microscope, DS-Fi1 1.0X camera. Bar
represents 100 mm. (E) Total RNA was
isolated from whole colonic tissue
isolated at different time intervals of
DSS administration as described (D),
and netrin-1 transcript levels (Ntn-1)
were determined by real-time reverse
transcriptase polymerase chain
reaction (RT-PCR). Ntn-1 expression
was calculated relative to b-actin and
expressed as fold change relative to
water-exposed mice6SEM. (F) Whole
colon was harvested following DSS exposure as described (D). Total protein was isolated, and netrin-1 (Ntn-1) expression at 7 days post DSS was
determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with b-actin as loading control. (G) Colonic mucosal scrapings
were harvested post DSS (described in D). Netrin-1 (Ntn-1) expression in the mucosal layer at 7 days post DSS was determined by SDS-PAGE with b-
actin as loading control. In vivo DSS time course data represent five mice per time point, and western blot data are representative of greater than three
independent experiments with six to eight mice per group.
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natural killer cell (NK1.1+), eosinophil (SiglecF+), macrophage
(F4/80+), B cell (B220+), CD4 T cell (CD4+), CD4 T-regulatory
cell (CD4+CD25+FoxP3+), CD8 T cell (CD8+) or CD8 T-
suppressor cell (CD8+CD103+) frequency or number between
Ntn-1+/ mice and Ntn-1+/+ controls (data not shown).
However, following 3 (figure 4A,B) and 7 days (figure 4C) of
DSS, a dramatic and sustained increase was observed in the
frequency and number of neutrophils (Gr-1+ cells) in the LP of
Ntn-1+/ mice compared with Ntn-1+/+. Specificity of the
netrin-1 effect on this granulocyte population is demonstrated
by the dot plot revealing no change in eosinophil frequency
(SiglecF+ cells) between the two groups (figure 4A). Addition-
ally, expression levels of the pro-inflammatory cytokines TNFa
(figure 4D) and IL-1b (figure 4E) were significantly enhanced in
Ntn-1+/ mice following 7 days of DSS, confirming the exag-
gerated inflammatory response observed in these mice.
Netrin-1 treatment attenuates disease severity during
experimental colitis
The observation that netrin-1 deficiency exacerbates DSS-colitis
directed us to investigate the consequences of supplementation
with netrin-1 in this model. Mice that were treated
with recombinant mouse netrin-1 for 7 days (1 mg/mouse/day)
experienced diminished disease severity as demonstrated by
body weight loss, disease activity index, histologic damage and
colonic shortening (figure 5AeD, respectively) compared with
vehicle-treated controls. Reduced inflammation in these mice
was indicated by decreased TNFa and IL-1b colonic expression
following netrin-1 treatment (figure 5EeF). These observations
indicate that treatment with exogenous netrin-1 exerts
a protective effect in experimental colitis.
Netrin-1 does not affect epithelial barrier function
Epithelial barrier dysfunction is a key feature of human UC and
a major component of DSS-colitis.32 The prominent influx of
neutrophils into the LP of Ntn-1+/ mice compared to wild-type
controls (Ntn-1+/+), particularly at early onset of DSS-colitis
(day 3, figure 4B), led us to investigate netrin-1 effects on
epithelial barrier function. Furthermore, netrin-1 signalling has
been implicated in antiapoptotic effects on intestinal epithelial
cells33; therefore, we could hypothesise that netrin-1 mediates
protection during DSS by inhibiting intestinal epithelial cell
apoptosis.
For this purpose, serum levels of FITC were determined
following gavage with FITC-dextran (4 kDa) in Ntn-1+/ mice
compared to wild-type controls after 3 days of DSS. This day
was chosen as epithelial barrier dysfunction occurs at early time
points post DSS32 and Ntn-1+/ mice experience significantly
differential body weight loss by day 3 (figure 3A). No difference
in epithelial permeability was noted between the Ntn-1+/ and
wild-type water controls. DSS exposure resulted in a significant
increase in serum FITC in wild-type mice compared to their
water controls. Importantly, we observed no additional increase
in permeability in Ntn-1+/ mice following DSS compared to
wild-type counterparts (figure 6A). This indicates that loss of
netrin-1 expression does not directly affect epithelial barrier
function. This study was repeated in mice treated with
exogenous netrin-1 (1 mg/mouse/day) at the same time point
Figure 2 Netrin-1 expression and
enteric neuronal patterning in mice with
partial netrin-1 deficiency following
DSS-colitis. Age-, weight-, and sex-
matched mice with partial netrin-1
deficiency (Ntn-1+/) and their wild-
type controls (Ntn-1+/+) were exposed
to water or DSS (4.5%) for 7 days,
followed by sacrifice and harvesting of
the whole colon by blunt dissection. (A)
Total RNA was extracted, and Ntn-1
transcript levels determined by real-
time reverse transcriptase polymerase
chain reaction (RT-PCR). Ntn-1
expression was calculated relative to
b-actin and expressed as fold change
relative to water-exposed Ntn-1+/+
mice6SEM. (B) Total protein was
extracted, and Ntn-1 levels were
determined by sodium dodecyl sulfate
polyacrylamide gel electrophoresis
(SDS-PAGE) with b-actin as the loading
control. (C) Densitometric analysis of
netrin-1 expression in mucosal
scrapings as mean fold change relative
to water-exposed Ntn-1+/+
mice6SEM. Results are representative
of at least three independent
experiments with six to eight mice per
group. (D) Representative images of
immunofluorescence staining
performed on frozen sections from
whole colon of mice with partial netrin-
1 deficiency (Ntn-1+/) or wild-type
controls
(Ntn-1+/+) exposed to water or DSS using an anti-PGP9.5 antibody (red) and counterstaining with DAPI (blue). Images were acquired with a QImaging
Retiga-400RV at 10X. Bar represents 100 mm. Results represent analysis of mice at 3 and 7 days post DSS stained as a whole mount and in sequential
sections (n¼2 mice per group).
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post DSS. These mice experience improved disease outcome
compared to vehicle-treated controls (figure 5). Mice exposed
to DSS demonstrated significant increase in serum FITC
compared to water controls as previously noted32; netrin-1
treatment had no effect on barrier function as measured by
serum FITC levels (figure 6B). To more specifically analyse the
effect of netrin-1 on intestinal epithelial cell apoptosis, colonic
sections from mice treated with vehicle or netrin-1 exposed to
water or DSS for 6 days were TUNEL stained (figure 6C,D).
Limited basal intestinal epithelial cell apoptosis was identified in
water controls which was unaltered by netrin-1 treatment
(figure 6C,D; arrows indicate apoptotic nuclei). The percentage
of apoptotic colonic epithelial cells was dramatically enhanced
in mice exposed to DSS, as previously noted.34 Netrin-1 treat-
ment during DSS did not alter the percentage of apoptotic
epithelial cells (figure 6C,D). Taken together, these studies
indicate that the protection conveyed by endogenous or exoge-
nous netrin-1 during experimental colitis does not primarily
involve modulation of intestinal barrier function or epithelial
cell apoptosis.
In vitro experiments using Caco-2 intestinal epithelial cells as
a model of epithelial barrier function confirmed in vivo findings.
High-resistance Caco-2 monolayers were treated with DSS
(4.5%; basolaterally and apically) for 6 h (figure 6E) or cytokine
cocktail for 48 h (basolateral IFNg, TNFa, IL-1b; all at 10 ng/ml;
figure 6F,G). Co-incubation with netrin-1 at the basolateral
membrane or at both sides of the membrane (data not shown for
cytomix) had no effect on barrier function as measured by
transepithelial electrical resistance (TEER; figure 6E,F) or by FITC-
dextran (3 kDa) flux performed at 48 h post cytomix treatment
(figure 6G), supporting in vivo findings that netrin-1 does not
directly modulate the intestinal epithelial barrier function.
Netrin-1 limits colonic leucocyte infiltration to attenuate
inflammation in experimental colitis
Our previous observation of increased neutrophil (Gr-1+ cells)
accumulation within the LP of netrin-1-insufficient mice (figure
4AeD) coupled with studies indicating that netrin-1 regulates
leucocyte transmigration2 6 prompted investigation of the
effects of exogenous netrin-1 on leucocyte migration. Trans-
migration of neutrophils across the epithelial barrier is a
morphologic hallmark of colitis.29 35 36 Initial investigation
revealed that netrin-1 suppressed chemo-attractant-induced
(Formyl-Methinyl-Leucyl-Phenylalanine; fMLP) human neutro-
phil (PMN) transmigration across a Caco-2 intestinal epithelial
barrier in a concentration-dependent manner (figure 7A), in
support of previous observations 2 6 and our conclusions from
initial in vivo studies (figure 4A-C). Flow cytometric analysis
revealed that the frequency and number of Gr-1+ neutrophils
within the LP were significantly attenuated following netrin-1
treatment during DSS compared to vehicle-treated controls
(figure 7B). Previous studies demonstrated that netrin-1 can
Figure 3 Disease activity in mice
with partial netrin-1 deficiency during
DSS-colitis. Gender-, age- and weight-
matched mice with partial netrin-1
deficiency (Ntn-1+/) and their wild-
type controls (Ntn-1+/+) were exposed
to DSS (4.5%) for 7 days, followed by
sacrifice and harvesting of the whole
colon by blunt dissection. (A) Daily
weight measurements were obtained
for each group of mice. p<0.05 as
measured by analysis of variance
(ANOVA). (B) Daily disease activity
measurements encompassing weight,
stool consistency and presence of
blood were assessed for each group of
mice. p<0.05 as measured by ANOVA.
(C) At harvest, colon length was
measured for each mouse and is
displayed as the mean6SEM. (D)
Representative histological sections
from whole colon of Ntn-1+/+ or
Ntn-1+/ mice harvested following
7 days of DSS or water. Bar represents
100 mm. Images acquired at 10X using
Olympus BX51. (E) Blinded histological
scoring of colonic tissue post DSS. All
results are representative of three
independent experiments with six to
eight mice per group and are displayed
as mean6SEM.
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limit neutrophil and monocyte recruitment during instances of
acute tissue injury.6 10 Given that the anti-Gr-1 antibody
recognises Ly-6G and Ly-6C antigens, with Ly-6G representing
a specific neutrophil surface marker and Ly-6C acting as a marker
for inflammatory monocytes/macrophages,37 we sought to
dissect whether netrin-1 was limiting transmigration of both
cell types to the LP during DSS-colitis. Flow cytometric analysis
of leucocytes isolated from the LP of vehicle- and netrin-1-
treated mice demonstrated that the frequency and number of
Ly-6GHiCD11b+ neutrophils were considerably increased during
DSS-colitis compared to water controls, with both parameters
being significantly diminished by netrin-1 treatment (supple-
mentary figure 1AeC). To negate neutrophilic contribution due
to binding of Ly-6C to neutrophils, the frequency of monocyte
populations was assessed gating on Ly-6G negative cells. The
frequency and number of Ly-6C high (Ly6G-Ly-6CHiCD11b+)
and Ly-6C intermediate (Ly6G-Ly-6CIntCD11b+) monocytes/
macrophages were augmented during DSS but were not signif-
icantly altered by netrin-1 (supplementary figure 1D,E). There-
fore, detailed flow cytometric analysis using two distinct
markers for neutrophil recognition demonstrates that netrin-1
can significantly attenuate neutrophil recruitment to the
LP during DSS. Our analysis reveals no distinct effect of netrin-1
on monocyte/macrophage tissue infiltration during DSS.
Therefore, we conclude that netrin-1 is part of an endogenous
protective pathway within the colonic epithelium that dampens
DSS-colitis through preferential limitation of neutrophil tissue
infiltration.
Purinergic signalling pathways contribute to netrin-1-mediated
protection from experimental colitis
Having identified that netrin-1 mediates protection during DSS-
colitis through limitation of leucocyte recruitment, we
proceeded to investigate the specific netrin-1 receptor involved.
Previous study has demonstrated significant levels of expression
of the UNC5B (uncoordinated receptor 5B) receptor and Adora2b
(A2B adenosine receptor) on leucocytes which have each
been demonstrated to mediate netrin-1 protective effects in
models of acute inflammation.2 6 8 10 Taking this into account,
we initially performed an antibody blocking study of the
UNC5B receptor using a strategy shown to be effective in
reversing netrin-1-mediated protection in a model of renal
ischaemia.10 Anti-UNC5B blocking antibody or control immu-
noglobulin (Ig) G was administered (800 mg/kg/mouse) 1 day
prior to commencement of netrin-1 delivery (1 mg/mouse/day)
and 2 days prior to DSS with blocking antibody or control IgG
administration at 2-day intervals until day 6 post DSS (day 2,
0, 2, 4) when mice were sacrificed. Consistent with previous
results (figure 5), netrin-1 significantly attenuated severity of
DSS-colitis as measured by weight loss, colon shortening and
histologic tissue injury (figure 8AeC, respectively). Co-admin-
istration of a UNC5B blocking antibody did not alter netrin-1-
mediated protection, with mice exhibiting no differences in
weight loss, colon length or histologic injury to those treated
with control IgG (figure 8AeC), thus indicating that netrin-1
was not acting through UNC5B to protect in DSS.
Subsequent studies were performed with Adora2b-deficient
mice (Adora2b/; figure 8DeF). Adora2b/ mice treated with
netrin-1 (1 mg/mouse/day with subcutaneous pump) demon-
strated comparable disease activity as measured by weight loss,
colon shortening or histologic injury (figure 8DeF) compared
to vehicle-treated Adora2b/ controls. Consistent with
previous studies in acute inflammatory models,2 8 we observed
that netrin-1-mediated protection during DSS-colitis involves
adenosine receptors.
DISCUSSION
CD and UC are chronic relapsing disorders of the gastrointes-
tinal tract which exert devastating personal and professional
consequences on the approximately 1 million sufferers.14 Disease
progression is relentless, with the eventual outcome being
surgical intervention for up to 70% of patients.38 39 The era of
the biologics has ushered in hope for improving therapeutic
strategies; however, this approach is not without serious
p
p p
p
p
p
p
p p
p p
p
Figure 4 Colonic inflammatory infiltrate following DSS-colitis in Ntn-1+/
+ and Ntn-1+/ mice. Gender-, age- and weight-matched mice with
partial netrin-1 deficiency (Ntn-1+/) and their wild-type controls (Ntn-
1+/+) were exposed to DSS (4.5%) for 3 or 7 days, followed by sacrifice
and harvesting of the whole colon by blunt dissection. Colonic lamina
propria leucocytes were isolated, and flow cytometric analysis of GR-1+
(neutrophils) and SiglecF+ (eosinophils) granulocytes was performed. (A)
Representative dot plots showing GR-1+ granulocytes from the colonic
lamina propria of Ntn-1+/+ and Ntn-1+/ mice post DSS. (B) The number
of GR-1+ granulocytes in the colonic lamina propria following 3 days of
water or DSS in Ntn-1+/+ and Ntn-1+/ mice. (C) The number of GR-1+
granulocytes in the colonic lamina propria following 7 days of water or
DSS in Ntn-1+/+ and Ntn-1+/ mice. (D, E) Following whole colon
harvest, total RNA was extracted, and tumor necrosis factor (TNF) a (D)
or interleukin (IL) 1b (E) transcript levels were determined by real-time
reverse transcriptase polymerase chain reaction (RT-PCR). Gene
expression was calculated relative to b-actin and expressed as fold
change relative to water-exposed Ntn-1+/+ mice6SEM. Results
represent two independent experiments with four mice per group (flow
cytometry) or six to eight mice per group (RT-PCR).
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contraindications and adverse events.14 There remains an urgent
need for novel therapeutics particularly to control the exagger-
ated inflammation within the intestine of patients with IBD.
Recent studies have implicated the neuronal guidance molecule
netrin-1 in mediating tissue inflammatory responses.2 6e9
Particularly, netrin-1 expression was shown to be induced under
conditions of limited oxygen availability and to ameliorate
hypoxia-driven inflammation.2 Based on these findings,
we hypothesised that netrin-1 could represent an endogenous
anti-inflammatory in the context of IBDda condition that is
also characterised by profound tissue hypoxia.19 Excitingly, our
studies revealed that mice with partial netrin-1 deficiency (Ntn-
1+/) demonstrated increased disease susceptibility in a model of
DSS-colitis. This was associated with a robust neutrophil infil-
tration into the colonic LP and a significant increase in tissue
cytokine levels in the Ntn-1+/mice compared to their wild-type
controls. Conversely, supplementation with exogenous netrin-1
was associated with attenuated weight loss, improved tissue
histology and diminished colonic inflammation. Moreover,
mechanistic studies pointed towards a role for netrin-1 in pref-
erentially dampening neutrophil tissue infiltration rather than
improving intestinal barrier function or attenuating intestinal
epithelial cell apoptosis. Studies using antibody blockade of the
UNC5B receptor or gene-targeted mice for the Adora2b point
towards adenosine-receptor-mediated netrin-1 protection during
DSS-colitis. Together, these studies demonstrate for the first
time a role of netrin-1 in the suppression of intestinal inflam-
mation as occurs in the context of IBD.
Consistent with our observations, previous studies have
demonstrated that netrin-1 is induced by inflammatory signalling
pathways in intestinal epithelia via NFkB (nuclear factor k B)
signalling.27 We demonstrate that netrin-1 expression is enhanced
at the protein and mRNA level during the course of DSS-colitis.
Despite netrin-1 mRNA upregulation by inflammatory
Figure 5 Exogenous netrin-1
treatment in DSS-colitis. Gender-, age-
and weight-matched C57BL/6 mice
were treated with netrin-1 (1 mg/
mouse/day) or vehicle (1% bovine
serum albumin (BSA)/phosphate-
buffered saline (PBS)) using
a subcutaneous osmotic pump
beginning 1 day prior to administration
of (day 1) water or DSS (4.5%) for
6 days, followed by sacrifice and
harvesting of the whole colon by blunt
dissection. (A) Daily weight
measurements were obtained for each
group of mice. p<0.05 by analysis of
variance (ANOVA). (B) Assessment of
daily disease activity measurements,
encompassing weight, stool
consistency and presence of blood,
was performed for each group of mice.
p<0.05 by ANOVA. (C) Representative
histological images from vehicle- and
netrin-1-treated mice exposed to water
or 4.5% DSS. Bar represents 100 mm.
Images acquired at 10X using Olympus
BX51. Bar graph of blinded histological
scoring of colonic tissue post treatment
displayed as the mean6SEM. (D) Colon
length measurements for each mouse
were taken following harvest at day 6
post DSS and are displayed as
mean6SEM. (E, F) Following whole
colon harvest, total RNA was extracted,
and tumor necrosis factor (TNF) a (E)
or interleukin (IL) 1b (F) transcript
levels were determined by real-time
reverse transcriptase polymerase chain
reaction (RT-PCR). Gene expression
was calculated relative to b-actin and
expressed as fold change relative to
water-exposed vehicle-treated
mice6SEM. Results represent 3
independent experiments with six to
eight mice per group.
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stimulation of HMEC-1 endothelial cells, immunohistochemical
analysis of the murine colon during DSS revealed limited, if
any, detectable expression of netrin-1 at the level of the endo-
thelium. However, netrin-1 protein was robustly expressed in the
intestinal epithelium where it appears to be increased during DSS
exposure. This correlates with enhanced netrin-1 expression
observed in the intestinal epithelia of patients with CD and
UC.15 Consistent with these studies, netrin-1 induction in IBD
could involve the NFkB pathway.27 However, a recent study
demonstrates that HIF-1a (hypoxia-inducible factor 1a), a tran-
scription factor stabilised in intestinal epithelia in murine models
of IBD,19 can induce netrin-1 expression in intestinal epithelia.2
Additionally, the Ets-1 transcription factor that is upregulated
during IBD40 has been shown to induce netrin-1 expression in
melanocytes.41 Therefore, multiple pathways can regulate netrin-
1 expression in the context of inflammation.
Immunohistochemical analysis revealed consistent expression
of netrin-1 in colonic myenteric neural units during DSS. Recent
studies demonstrated a role for netrin-1 in the developing enteric
nervous system where enteric neural-derived crest cells produce
netrin-1.42 This intriguing observation led us to analyse the
enteric neuronal anatomy of netrin-1-insufficient mice during
DSS-colitis. Independent analysis revealed no difference in the
enteric neuronal anatomy of netrin-1-insufficient mice in
comparison with their wild-type controls either at baseline or
during disease course. We conclude that netrin-1 insufficiency
does not alter the neuronal anatomy in adult mice prior to or
during DSS.
Figure 6 Netrin-1 effects on the
intestinal epithelial barrier. (A) Mice
with partial netrin-1 deficiency
(Ntn-1+/-) and their wild-type controls
(Ntn-1+/+) were exposed to DSS for
3 days (described in figure 3) prior to
oral gavage with FITC-dextran (4 kDa;
0.6 mg/g at 80 mg/ml). Fluorescence
measurement (478 nm) was used to
determine FITC in the serum 4 h later
and is displayed as mean FITC (mg/
ml)6SEM. (B) Mice with vehicle or
netrin-1 treatment (described in figure
5) were exposed to DSS for 3 days
prior to oral gavage with FITC-dextran
(4 kDa 0.6 mg/g at 80 mg/ml), and
serum FITC levels were determined and
displayed as described in A.
(C) Representative images of apoptotic
colonic epithelial cells identified by
TUNEL staining of paraffin-embedded
colonic sections following treatment of
mice with netrin-1 or vehicle and
exposure to DSS for 6 days (described
in figure 5). Images were acquired at
20X using a Nikon Eclipse Ti-S
microscope, DS-Fi1 1.0X camera and
represent at least six mice per group.
(D) Quantification of the percentage of
apoptotic colonic epithelial cells in
vehicle- or netrin-1-treated mice
following 6 days of DSS exposure
(described in figure 5). Scoring was
carried out in a blinded fashion with
counting of 600 cells over three
randomly selected fields per section
with six mice per group. (E) Caco-2
intestinal epithelial monolayers cultured
as monolayers on transwell permeable
supports for at least 3 weeks prior were
exposed to 4.5% DSS in the apical and
basolateral chamber, with vehicle or
human recombinant netrin-1 (500 ng/
ml) co-treatment. Transepithelial
electrical resistance (TEER)
measurements were taken at time
intervals indicated (24 h not shown)
and are displayed as mean resistance measurements (Ohms.cm2)6SEM. (F) Caco-2 cells were cultured as described (E) prior to basolateral treatment
with tumor necrosis factor (TNF) a, interleukin (IL) 1b and interferon (IFN) g (cytomix; all 10 ng/ml) plus vehicle or human recombinant netrin-1
(500 ng/ml) for 48 h. TEER measurements were taken at time intervals indicated. (G) FITC-dextran (3 kDa; 250 mg/ml) was applied to the apical
compartment of Caco-2 monolayers treated for 48 h as described in F. Appearance of FITC in the basolateral compartment was measured over a 3 h
period and analysed as described in A. Results displayed as the apparent permeability of the monolayer (Papp; cm2/s). In vivo FITC measurements
represent five mice per group. In vitro experiments represent four individual wells per treatment from two separate experiments.
702 Gut 2012;61:695e705. doi:10.1136/gutjnl-2011-300012
Inflammatory bowel disease
 o
n
 February 26, 2020 at M
aynooth University Library. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2011-300012 on 3 August 2011. Downloaded from 
Supporting our observations, an anti-inflammatory effect of
netrin-1 has been observed in models of acute inflammation.2 6e9
Originally, netrin-1 was demonstrated to attenuate LPS-induced
sepsis through inhibition of leucocyte migration.6 Studies in
kidney ischaemiaereperfusion injury,7 10 hypoxia-induced
inflammation,2 acute lung injury8 43 and peritonitis9 support this
observation by demonstrating a tissue-protective role for netrin-1
through suppression of inflammation. Presently, a number of
downstream receptor signalling pathways have been implicated
in netrin-1-mediated tissue protection observed in these studies.
The transmembrane receptors, deleted in colorectal cancer,
uncoordinated receptor 5 (mouse UNC5A-D; human UNC5H1-4)
and the A2B adenosine receptor (ADORA2B/Adora2b) represent
the known netrin-1 receptors.2 6 8e10 44 45 Independent studies
have demonstrated that either UNC5B or Adora2b expression on
leucocytes is responsible for netrin-1 inhibition of tissue
inflammation.2 6 8e10 Of additional relevance to the present
study is the observation that netrin-1 receptors can mediate the
apoptotic response of the intestinal epithelium.33 Enforced
expression of netrin-1 in the intestinal epithelium resulted in
decreased epithelial apoptosis and a modest increase in tumour
formation in the presence of APC mutation.33 Furthermore,
blockade of netrin-1 interaction with epithelial deleted in colo-
rectal cancer receptor enhanced tumour cell death in a model of
colorectal cancer progression.15 Intestinal epithelial cell
apoptosis, along with alterations in epithelial tight junction
formation, is central to the mucosal disruption observed in
patients with IBD.46 47 Similarly, epithelial cell apoptosis and
tight junction breakdown are key features of DSS-colitis, while
inhibition of apoptosis in this model is barrier protective.34 48
Therefore, it is conceivable that antiapoptotic effects of netrin-1
signalling may be central to its beneficial effects during experi-
mental colitis. In vitro studies of cytokine-induced tight junc-
tion rearrangement reveal no effect of netrin-1 on this aspect of
epithelial permeability.49 Importantly, in vitro and in vivo
studies indicate that netrin-1 does not influence DSS-induced
epithelial barrier disruption and does not have a direct impact on
intestinal epithelial cell apoptosis.
In addition to epithelial barrier breakdown, early and persis-
tent infiltration of neutrophils into the LP forming crypt
abscesses is a key feature of human disease and murine
colitis.29e32 36 The full extent of the role that neutrophils play
during DSS-colitis remains controversial. Studies using direct
depletion of neutrophils with anti-Gr1 prior to DSS reveal
modest effects of neutrophil depletion on early disease activity
but no significant effect on disease outcome.50 51 However, the
authors propose that macrophages are key regulators of DSS-
colitis that mediate protective effects through limitation of
neutrophil infiltration.50 Interestingly, one study identified
neutrophil depletion leading to worsening disease during DSS-
colitis.52 Conversely, therapeutic targeting of neutrophil
recruitment to the colon in models of colitis using blockade of
the neutrophil chemokine receptor (CXCR2) or ligand (CXCL5)
results in diminished neutrophil recruitment during DSS and
amelioration of disease.53e55 Taken together, these studies
suggest that while complete blockade of neutrophil recruitment
during colitis might not be desirable, limitation of the neutrophil
influx into the LP would act to control disease severity. Present
in crypt abscesses during human disease are other leucocyte
populations including monocytes/macrophages and lympho-
cytes. Therapeutic strategies in human disease and mouse
models to deplete granulocytic and monocytic tissue infiltration
have met with some success.56 57 Therefore, treatment to
attenuate tissue infiltration of granulocytes and monocytes may
be of therapeutic benefit. In support of these studies, we
demonstrate that netrin-1 directly limits trafficking of neutro-
phils in vitro and in vivo to ameliorate outcome in DSS-colitis.
Further dissection of netrin-1 effects on leucocyte recruitment
during DSS-colitis indicates that netrin-1 has no discernible
effect on monocyte/macrophage recruitment to the colonic LP.
Therefore, this study presents the preferential limitation of
neutrophil recruitment by netrin-1 during DSS as a novel ther-
apeutic strategy in an acute model of colitis.
Present findings place netrin-1 as an endogenous protective
mediator in experimental colitis. Interestingly, supplementation
with netrin-1 in DSS-colitis where its expression is induced is
therapeutically effective. A similar phenomenon is observed in
two independent studies where stabilisation of the locally
produced HIF-1a transcription factor during experimental colitis
Figure 7 Netrin-1 effects on inflammatory infiltrate in vitro and in vivo.
(A) Neutrophils (PMN) were harvested from whole human blood and
applied at 1X106 PMN in the presence of vehicle or increasing
concentrations of human recombinant netrin-1 (50e500 ng/ml) to the
basolateral aspect of Caco-2 intestinal epithelial cells grown to
confluence on inverted permeable supports. fMLP (1 mM) was added to
the apical aspect of each well. Presence of transmigrated neutrophils in
the apical compartment was measured by myeloperoxidase levels and is
displayed as the mean fold change in PMN numbers relative to
vehicle6SEM. Results represent at least triplicate wells from three
independent experiments. (B) C57BL/6 mice were treated with netrin-1
(1 mg/mouse/day) or vehicle prior to exposure to water or DSS as
described in figure 5. Following colon harvest at day 6 post DSS, colonic
lamina propria leucocytes were isolated, and flow cytometric analysis of
GR-1+ (neutrophils) and SiglecF+ (eosinophils) granulocytes was
performed. The number of GR-1+ granulocytes is displayed as
mean6SEM for four mice.
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is of therapeutic benefit.16 18 These studies support the potential
benefit of enhancing in vivo protective responses for therapeutic
intervention.
As previously mentioned, netrin-1 has an array of receptors
through which it mediates tissue-protective effects. We focused
our studies on receptors that have been implicated in mediating
netrin-1-driven inhibition of leucocyte recruitment in models of
acute inflammation, the UNC5B and the Adora2b. Lack of
functional Adora2b abrogated the protective effect of netrin-1 on
DSS-colitis. These studies implicate this purinergic signalling
pathway in netrin-1-mediated protection in experimental colitis.
Consideration of netrin-1 as a therapeutic strategy in IBD
must take into account the breadth of literature demonstrating
the anti-inflammatory component as well as the antiapoptotic
role of netrin-1 signalling. Studies indicating the involvement of
netrin-1 in malignant transformation in the intestine,15 coupled
with our observation that netrin-1 significantly attenuates
intestinal leucocyte infiltration in experimental colitis, point to
a tailored therapeutic strategy with netrin-1 administration
perhaps being more suited to treat periods of disease flare rather
than a maintenance treatment.
In summary, our present studies demonstrate for the first time
that netrin-1 expression is an endogenous tissue-protective
mechanism in experimental colitis. Therapeutic studies indicate
that targeting netrin-1 may be useful in treatment of aberrant
intestinal leucocyte accumulation, as occurs in colitis.
Figure 8 Specific blockade of netrin-1
receptors during exogenous netrin-1
treatment in DSS-colitis. (A) Gender-,
age- and weight-matched C57BL/6
mice were treated with anti-UNC5B
antibody (800 mg/kg) or control goat
immunoglobulin (Ig) G (800 mg/kg)
intraperitoneally 2 days prior to
administration of water or DSS (3.5%)
followed by repeated administration of
blocking antibody or control IgG at days
0, 2, and 4 of DSS exposure. Netrin-1
(1 mg/mouse/day) or vehicle (1% bovine
serum albumin (BSA)/phosphate-
buffered saline (PBS)) delivery using
a subcutaneous osmotic pump
commenced 1 day prior to
administration (day 1) of water or
DSS for 6 days, followed by sacrifice
and harvesting of the whole colon by
blunt dissection. (A) Daily weight
measurements were obtained for each
group of mice. p<0.05 by analysis of
variance (ANOVA). (B) Colon length
measurements for each mouse were
taken following harvest at day 6 post
DSS and are displayed as mean6SEM.
(C) Representative histological images
from (i) water controls, (ii) DSS-
exposed mice treated with control IgG
and BSA/PBS vehicle, (iii) DSS-exposed
mice treated with netrin-1 and control
IgG and (iv) DSS-exposed mice treated
with netrin-1 and anti-UNC5b antibody.
Bar represents 100 mm. Images
acquired at 10X using an Olympus
BX51. (DeF) Gender-, age- and weight-
matched A2B receptor-deficient mice
(Adora2b/) were treated with netrin-
1 (1 mg/mouse/day) or vehicle (1%
BSA/PBS) using a subcutaneous
osmotic pump commencing 1 day prior
to administration (day 1) of water or
DSS (3.5%) for 6 days, followed by
sacrifice and harvesting of the whole
colon by blunt dissection. (D) Daily
weight measurements were obtained
for each group of mice. (E) Colon length
measurements for each mouse were
taken following harvest at day 6 post
DSS and are displayed as mean6SEM.
(F) Representative histological images
from (i) water controls, (ii) DSS-exposed mice treated with BSA/PBS vehicle and (iii) DSS-exposed mice treated with netrin-1. Bar represents 100 mm.
Images acquired at 10X using an Olympus BX51. Experiments are representative of six to eight mice per group.
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